Thermo Fisher Scientific | TMO - Debt



Thermo Fisher Scientific reported $34.19B in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Abbott USD 13.44B 195M Jun/2025
Agilent USD 3.41B 86M Jul/2025
Becton, Dickinson and Co. USD 19.34B 71M Jun/2025
Bio Techne USD 346M 16M Jun/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Boston Scientific USD 11.31B 563M Mar/2025
Bruker USD 2.44B 321.5M Jun/2025
Charles River Laboratories USD 2.79B 275.28M Jun/2025
Danaher USD 17.36B 878M Jun/2025
Dentsply International USD 2.49B 159M Jun/2025
Edwards Lifesciences USD 699.4M 101.7M Mar/2025
Exact Sciences USD 2.32B 16.28M Jun/2025
General Electric Aerospace USD 18.89B 684M Jun/2025
Henry Schein USD 3.36B 467M Jun/2025
Hologic USD 2.52B 8.5M Jun/2025
Illumina USD 2.6B 608M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Laboratory Of America USD 6.52B 107.7M Mar/2025
Medtronic USD 28.52B 1.91B Apr/2025
Mettler Toledo International USD 2.18B 109.83M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Olympus JPY 229.1B 4.23B Mar/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Stryker USD 16.58B 201M Jun/2025
Thermo Fisher Scientific USD 34.19B 2.91B Mar/2025
Veracyte USD 50.5M 50.5M Mar/2025
Waters USD 1.54B 81.64M Jun/2025
Zimmer Biomet Holdings USD 7.57B 396.2M Jun/2025